Sartorius Stedim Biotech Stock Forecast

Hold candidate since Jul 28, 2026

No changes to the price of Sartorius Stedim Biotech stock on the last trading day (Friday, 31st Jul 2026). During the last trading day the stock fluctuated 0% from a day low at $193.00 to a day high of $193.00. The price has been going up and down for this period, and there has been a -11.69% loss for the last 2 weeks.

The stock lies in the lower part of a wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $187.88 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 6.10% during the next 3 months and, with a 90% probability hold a price between $199.34 and $233.86 at the end of this 3-month period.

SDMHF Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, July 21, 2026, and so far it has risen 0.783%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Sartorius Stedim Biotech stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $201.29. On a fall, the stock will find some support from the short-term average at $192.86. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Sartorius Stedim Biotech stock

Sartorius Stedim Biotech finds support from accumulated volume at $190.88 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

Sartorius Stedim Biotech is oversold on RSI14 (5). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: $180.05 (-6.71%) (This stock has very low daily movements and this gives very low risk. Low RSI14 is 5 which reduces the risk some. There is a buy signal from a pivot bottom found 8 days ago.)

Trading Expectations (SDMHF) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Sartorius Stedim Biotech to open at $193.00, and during the day (based on 14 day Average True Range), to move between $191.60 and $194.40, which gives a possible trading interval of +/-$2.81 (+/-1.47%) up or down from last closing price. If Sartorius Stedim Biotech takes out the full calculated possible swing range there will be an estimated 1.47% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $190.88 (1.10%) than the resistance at $199.90 (3.58%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Sartorius Stedim Biotech stock A Buy?

Sartorius Stedim Biotech holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $193.00 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk